No more painful biopsies? How a new blood test will transform cancer detection in Hong Kong
Hong Kong researchers are developing new blood tests to transform cancer detection, potentially eliminating the need for painful biopsies. This innovation, featured in a Health Matters series, aims to enable earlier cancer screenings and diagnoses.

Briefing Summary
AI-generatedHong Kong researchers are developing new blood tests to transform cancer detection, potentially eliminating the need for painful biopsies. This innovation, featured in a Health Matters series, aims to enable earlier cancer screenings and diagnoses. The article highlights the experience of Peter Wan Ying-keung, a retired businessman who faced a lengthy and uncomfortable diagnostic journey for prostate cancer 13 years ago, which began with an elevated PSA level in a routine blood test. These new blood tests are being developed by city researchers to improve the process of identifying cancer.
Article analysis
Model · rule-basedKey claims
4 extractedPeter Wan Ying-keung's journey to a prostate cancer diagnosis 13 years ago involved uncertainty and discomfort.
A routine blood test in 2013 showed elevated levels of prostate-specific antigen (PSA), a possible warning sign of cancer.
Researchers in Hong Kong are developing new blood tests to detect cancer earlier.
New blood tests could transform cancer screenings and diagnoses in Hong Kong.